• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌莫司汀对R-3327大鼠前列腺癌的抑制作用。

Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma.

作者信息

Müntzing J, Kirdani R Y, Saroff J, Murphy G P, Sandberg A A

出版信息

Urology. 1977 Nov;10(5):439-45. doi: 10.1016/0090-4295(77)90131-5.

DOI:10.1016/0090-4295(77)90131-5
PMID:919134
Abstract

Estracyt (estramustine phosphate) injected intraperitoneally, 100 mg, per Kg. three days a week for four weeks, retarded growth of the R-3327 tumor in intact rats and in orchiectomized rats given androgen. The growth inhibition was accomplished by reduction of tumor deoxyribonucleic acid concentration and of the activities of acid phosphatase, leucine aminopeptidase, and other hydrolases. Histologic examination revealed cellular necrosis particularly prominent in the orchiectomized, androgen-treated rats. Estracyt did not affect the uptake of 65-Zn in the tumors but markedly reduced the high uptake in the dorsolateral prostate. There was no accumulation of 3H or 14C in the tumors after intravenous administration of 3H, 14C-labeled Estracyt, but the isotope concentrations decreased much in the same way as they decreased in the dorsolateral prostate. The isotopes were retained in the ventral prostate, where their concentrations were approximately twenty times higher than those in the muscle four hours after injection. The results demonstrate the value of the R-3327 tumor in the evaluation of drugs of potential clinical use for the treatment of prostatic cancer. The results also show that Estracyt has an antitumor effect which is not dependent on the antigonadotropic action of the drug.

摘要

癌腺治(磷酸雌莫司汀)以每千克100毫克的剂量每周三天腹腔注射,持续四周,可抑制完整大鼠和接受雄激素治疗的去势大鼠体内R-3327肿瘤的生长。这种生长抑制是通过降低肿瘤脱氧核糖核酸浓度以及酸性磷酸酶、亮氨酸氨肽酶和其他水解酶的活性来实现的。组织学检查显示,细胞坏死在接受雄激素治疗的去势大鼠中尤为明显。癌腺治不影响肿瘤对65锌的摄取,但显著降低了背外侧前列腺的高摄取。静脉注射3H、14C标记的癌腺治后,肿瘤中没有3H或14C的积累,但同位素浓度的下降方式与背外侧前列腺相同。同位素保留在腹侧前列腺中,注射后四小时其浓度比肌肉中的浓度高约二十倍。结果证明了R-3327肿瘤在评估前列腺癌潜在临床治疗药物方面的价值。结果还表明,癌腺治具有抗肿瘤作用,且该作用不依赖于药物的抗促性腺作用。

相似文献

1
Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma.雌莫司汀对R-3327大鼠前列腺癌的抑制作用。
Urology. 1977 Nov;10(5):439-45. doi: 10.1016/0090-4295(77)90131-5.
2
[Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].一种新型前列腺癌治疗药物“雌莫司汀”的药理学与代谢
Gan To Kagaku Ryoho. 1984 Mar;11(3):537-44.
3
Antiprostatic effects of a nitrogen mustard of estriol.
Proc Soc Exp Biol Med. 1975 Mar;148(3):904-8. doi: 10.3181/00379727-148-38657.
4
Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan.雌莫司汀在大鼠前列腺中的潴留机制及日本雌二醇氮芥磷酸盐胶囊的临床试验结果。
Prostate. 1981;Suppl 1:95-102. doi: 10.1002/pros.2990020516.
5
Estramustine phosphate (Estracyt): experimental and clinical studies in Europe.磷酸雌莫司汀(癌腺治):欧洲的实验与临床研究
Semin Oncol. 1983 Sep;10(3 Suppl 3):27-33.
6
Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.在用雌二醇 - 3N - 双(2 - 氯乙基)氨基甲酸盐 - 17β - 磷酸盐(癌腺治)及其雌激素和细胞抑制剂部分进行体内治疗后,将³H - 胸腺嘧啶核苷和¹⁴C - 氨基酸掺入腹侧前列腺。
Invest Urol. 1976 Sep;14(2):85-92.
7
Uptake in vivo of 45Ca in male accessory sex organs of the rat: effect of estramustine phosphate and diethylstilbestrol diphosphate.大鼠雄性附属性器官对45Ca的体内摄取:磷酸雌莫司汀和己烯雌酚二磷酸酯的作用。
Eur J Pharmacol. 1981 Nov 19;76(1):87-91. doi: 10.1016/0014-2999(81)90013-3.
8
Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).磷酸雌莫司汀(癌腺治)治疗晚期前列腺癌
Scand J Urol Nephrol. 1977;11(3):231-8. doi: 10.3109/00365597709179957.
9
Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.磷酸雌莫司汀(癌腺治)代谢物在前列腺癌中的摄取情况。
J Urol. 1988 Nov;140(5):1058-62. doi: 10.1016/s0022-5347(17)41926-4.
10
[Clinical studies on serum lipids in the patients with tumor of the prostate gland. 2nd. Report. Changes of serum lipids and lipoprotein fractions during the treatment of estramustine phosphate disodium, hexestrol and diethylstilbestrol 4, 4-diphosphoric ester for the patients with prostatic cancer (author's transl)].
Nihon Hinyokika Gakkai Zasshi. 1980 Jan;71(1):59-69.

引用本文的文献

1
Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.磷酸雌莫司汀(癌腺治)在前列腺癌患者中的代谢
Eur J Drug Metab Pharmacokinet. 1981;6(2):149-54. doi: 10.1007/BF03189482.
2
Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.邓宁R3327H大鼠前列腺腺癌中的血流;雌二醇和睾酮的影响。
Urol Res. 1986;14(2):113-7. doi: 10.1007/BF00257897.
3
Presence of oestrogen receptors on target cells and antiproliferative activity of estramustine phosphate: positive correlation for human tumours in vitro.
靶细胞上雌激素受体的存在及磷酸雌莫司汀的抗增殖活性:体外人肿瘤的正相关关系
J Cancer Res Clin Oncol. 1991;117(3):244-8. doi: 10.1007/BF01625432.
4
Effect of estramustine phosphate (Estracyt) on transplantable mouse tumours.磷酸雌莫司汀(癌腺治)对可移植小鼠肿瘤的作用。
Urol Res. 1979 Dec;7(4):291-8. doi: 10.1007/BF00256611.